Earlier studies have clearly documented that in an already unstable genome as a result of BCR::ABL1 in CML, the emergence of ACAs might result in further genetic instability, aberrant cellular processes, and altered metabolism (25, 62, 63). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.